News
Latest News, Announcements, and Press Releases
03Mar 16
Codexis Reports 2015 Fourth Quarter and Full Year Financial Results
Meets 2015 Financial Guidance and Introduces 2016 Financial Guidance Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., March 03, 2016 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces financial results…
read more25Feb 16
Codexis to Hold 2015 Fourth Quarter and Full Year Conference Call on March 3
REDWOOD CITY, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2015 financial results after market close on Thursday, March 3, 2016. …
read more22Feb 16
Codexis Files Lawsuit against EnzymeWorks and CEO Junhua “Alex” Tao for Patent Infringement and Misappropriation of Trade Secrets
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Feb. 22, 2016– Codexis, Inc. (Nasdaq: CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces the filing of a lawsuit against EnzymeWorks and its founder, Junhua “Alex” Tao, for willful…
read more18Dec 15
Codexis Signs Multi-year Extension of Contract with Merck to Supply Enzyme Used in Manufacture of Sitagliptin
REDWOOD CITY, Calif., Dec. 18, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemicals industry, announces the signing of an agreement extension with Merck Sharp & Dohme Corp., known…
read more24Nov 15
Codexis to Present at LD Micro Main Event
REDWOOD CITY, Calif., Nov. 24, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces that management will present at the LD Micro Main Event on Wednesday, December…
read more04Nov 15
Codexis Reports Financial Results for the Third Quarter of 2015
Records net income of $5.4 million on revenues of $17.4 million Recognizes licensing agreement milestone payments totaling $11.5 million from GSK and Merck Affirms 2015 revenue guidance and raises gross margin guidance Conference call begins at 4:30 p.m.…
read more28Oct 15
Codexis to Hold 2015 Third Quarter Conference Call on November 4
REDWOOD CITY, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, today announced that it will report third quarter 2015 financial results after market close on Wednesday, November 4, 2015. Codexis management…
read more15Oct 15
Codexis Earns First Technology Transfer Milestone Payment From Merck
REDWOOD CITY, Calif., Oct. 15, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, today announced that it successfully completed Wave 1 of the transfer of its proprietary CodeEvolver® protein engineering platform technology to Merck,…
read more08Oct 15
Codexis Earns $6.5 Million Technology Transfer Milestone Payment From GSK
REDWOOD CITY, Calif., Oct. 8, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, today announced that it successfully completed Wave 2 of the transfer of its proprietary CodeEvolver® protein engineering platform technology to GlaxoSmithKline…
read more02Sep 15
Codexis to Present at Rodman & Renshaw Global Investment Conference
REDWOOD CITY, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces that management will present at the Rodman & Renshaw 17th Annual Global Investment…
read moreSince 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.
Unlock the power of proteins® with Codexis
Learn More
Company
Industries